Ocugen Inc.

11/19/2024 | Press release | Distributed by Public on 11/19/2024 06:36

Ocugen Announces Compelling Preliminary Data for OCU410—a Single Dose Novel Modifier Gene Therapy to Treat Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration